PREVALIN Trademark

Trademark Overview

On Friday, June 17, 2016, a trademark application was filed for PREVALIN with the United States Patent and Trademark Office. The USPTO has given the PREVALIN trademark a serial number of 79192976. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 12, 2024. This trademark is owned by Omega Pharma Innovation & Development NV. The PREVALIN trademark is filed in the Pharmaceutical Products category with the following description:

Preparations for the treatment of colds and infections of the respiratory system; preparations for the treatment of allergies
prevalin

General Information

Serial Number79192976
Word MarkPREVALIN
Filing DateFriday, June 17, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 12, 2024
Registration Number5229981
Registration DateTuesday, June 27, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2017

Trademark Statements

Goods and ServicesPreparations for the treatment of colds and infections of the respiratory system; preparations for the treatment of allergies
Translation of Words in MarkThe wording "PREVALIN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOmega Pharma Innovation & Development NV
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE
Party NameOmega Pharma Innovation & Development NV
Party Type30 - Original Registrant
Legal Entity Type32 - NOT AVAILABLE
AddressBE
Party NameOmega Pharma Innovation & Development NV
Party Type20 - Owner at Publication
Legal Entity Type32 - NOT AVAILABLE
AddressBE
Party NameOmega Pharma Innovation & Development NV
Party Type10 - Original Applicant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Trademark Events

Event DateEvent Description
Wednesday, October 12, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, October 1, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, October 13, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 13, 2016ASSIGNED TO EXAMINER
Friday, October 14, 2016NON-FINAL ACTION WRITTEN
Saturday, October 15, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 18, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, November 9, 2016REFUSAL PROCESSED BY MPU
Wednesday, November 9, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 9, 2016REFUSAL PROCESSED BY IB
Friday, January 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 2, 2017ASSIGNED TO LIE
Friday, February 10, 2017CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, February 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 7, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 21, 2017CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Wednesday, March 22, 2017NOTICE OF PUBLICATION
Wednesday, March 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, April 8, 2017NOTIFICATION PROCESSED BY IB
Friday, January 12, 2024CANCELLED SECTION 71
Tuesday, April 11, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, September 27, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, September 29, 2017GENERIC MADRID TRANSACTION CREATED
Friday, September 29, 2017GENERIC MADRID TRANSACTION SENT TO IB
Friday, November 10, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, March 12, 2022NEW REPRESENTATIVE AT IB RECEIVED
Thursday, April 14, 2022INTERNATIONAL REGISTRATION RENEWED
Sunday, May 19, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, May 19, 2024NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

prevalin preparations treatment system allergies infections colds respiratory